WTO declines to waive TRIPS provisions for COVID-19 drugs
25-01-2021
South Africa, India urge WTO to waive IP for COVID-19 treatments
08-10-2020
WTO 'expected to announce' 17-year drug patent waiver for LDCs
04-11-2015
EQroy / Shutterstock.com
Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation (WTO) to conclude an agreement.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
COVID-19, World Trade Organization, IP, TRIPS, drugs, UK, India, South Africa, vaccines
